The preparation of magnetic nanoparticles for applications in biomedicine

Journal of Physics D Applied Physics (Impact Factor: 2.53). 01/2003; 36:R182-R197. DOI: 10.1088/0022-3727/36/13/202

ABSTRACT This review is focused on describing state-of-the-art synthetic routes for the preparation of magnetic nanoparticles useful for biomedical applications. In addition to this topic, we have also described in some detail some of the possible applications of magnetic nanoparticles in the field of biomedicine with special emphasis on showing the benefits of using nanoparticles. Finally, we have addressed some relevant findings on the importance of having well-defined synthetic routes to produce materials not only with similar physical features but also with similar crystallochemical characteristics.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Iron oxide nanoparticles (NPs) with average sizes in the range 4–28 nm have been obtained by varying different synthesis parameters of the thermal decomposition of an iron precursor (iron stearate) in the presence of surfactants in high boiling solvents. The synthesis parameters affect the NPs nucleation and growth steps, by modifying the stability of iron stearate on which depend the monomer formation and concentration, in agreement with the LaMer model. The monomer formation, which is reaction time and/or temperature dependent, is thus found to vary mainly as a function of the nature of solvents and ligands. The structural and magnetic characterizations of NPs with sizes in the range 5–20 nm confirm that the composition of NPs evolves from the maghemite for small sizes (typically <8 nm) up to a core of rather stoichiometric magnetite surrounded by an oxidized shell for large sizes (>12 nm) via a perturbed oxidized state for intermediate sizes. The values of saturation magnetization lower than those of bulk magnetite and maghemite were found to be related to this composition evolution and to the presence of oxidation defects, surface spin canting and volume spin canting as a function of NPs diameter. Small NPs presented mainly a surface spin canting. NPs with large sizes display Ms which depends on their oxidized shell thickness, defects and surface spin canting. NPs with intermediate sizes display a surface and in particular a volume spin canting due to a disordered structure induced by a perturbed oxidation state in these NPs.
    The Journal of Physical Chemistry C 01/2014; 118(7):3795–3810. · 4.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanoclusters with plasmonic and magnetic properties are obtained with naked gold (AuNP) and iron oxide nanoparticles (FeOxNP) separately synthesized by laser ablation in water and simply assembled by using their opposite surface charges. Controlling the amount of AuNP and FeOxNP, we obtained nanoclusters with both good surface-enhanced resonance Raman scattering (SERRS) signals and superparamagnetic properties. Nanoclusters are incubated with murine macrophage cells which, after mixing with other macrophages, can be magnetically guided in solution by sorting them in less than 10 min. SERRS signals, observed at the single cell level, were recorded for the sorted macrophages, showing that the nanoclusters are active also in a biological environment and allow the identification of the incubated macrophage cells.
    The Journal of Physical Chemistry C 06/2014; 118(26):14534. · 4.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Iron oxide magnetic nanoparticles (MNPs) can be used in targeted drug delivery systems for localized cancer treatment. MNPs coated with biocompatible polymers are useful for delivering anticancer drugs. Iron oxide MNPs were synthesized via co-precipitation method then coated with either chitosan (CS) or polyethylene glycol (PEG) to form CS-MNPs and PEG-MNPs, respectively. Arginine (Arg) was loaded onto both coated nanoparticles to form Arg-CS-MNP and Arg-PEG-MNP nanocomposites. The X-ray diffraction results for the MNPs and the Arg-CS-MNP and Arg-PEG-MNPs nanocomposites indicated that the iron oxide contained pure magnetite. The amount of CS and PEG bound to the MNPs were estimated via thermogravimetric analysis and confirmed via Fourier transform infrared spectroscopy analysis. Arg loading was estimated using UV-vis measurements, which yielded values of 5.5% and 11% for the Arg-CS-MNP and Arg-PEG-MNP nanocomposites, respectively. The release profile of Arg from the nanocomposites followed a pseudo-second-order kinetic model. The cytotoxic effects of the MNPs, Arg-CS-MNPs, and Arg-PEG-MNPs were evaluated in human cervical carcinoma cells (HeLa), mouse embryonic fibroblast cells (3T3) and breast adenocarcinoma cells (MCF-7). The results indicate that the MNPs, Arg-CS-MNPs, and Arg-PEG-MNPs do not exhibit cytotoxicity toward 3T3 and HeLa cells. However, treatment of the MCF-7 cells with the Arg-CS-MNP and Arg-PEG-MNP nanocomposites reduced the cancer cell viability with IC50 values of 48.6 and 42.6 µg/mL, respectively, whereas the MNPs and free Arg did not affect the viability of the MCF-7 cells.
    Journal of Biomaterials Applications 01/2014; · 2.64 Impact Factor

Full-text (2 Sources)

Available from
May 23, 2014